— Know what they know.
Not Investment Advice

ANAB NASDAQ

AnaptysBio, Inc.
1W: -8.9% 1M: +17.3% 3M: +9.0% YTD: +33.0% 1Y: +195.6% 3Y: +207.3% 5Y: +134.9%
$59.77
+1.03 (+1.75%)
Pre-Market: $63.99 (+4.22, +7.06%)
Weekly Expected Move ±13.3%
$46 $55 $63 $72 $80
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 57 · $2.6B mcap · 40M float · 2.07% daily turnover · Short 44% of daily vol
Last Earnings 2026-03-03
EPS
$1.58
▲ Beat +77.5%
Revenue
$108M
▲ Beat +24.4%
EPS Beat Streak: 6 quarters
Next Earnings 2026-08-10
EPS Estimate
$-0.35
Range: $-0.59 - $-0.09
Revenue Estimate
$25M
3 analysts

Estimate vs Actual

Earnings Surprise History

10/18
EPS Beats
13/18
Revenue Beats
56%
EPS Beat Rate
72%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-15 quarter 2026-09-30 $-0.35 $-0.35 $25,701,565 $30,812,676
2026-05-15 annual 2028-12-31 $5.38 $5.26 ▼ 0.12 $298,681,493 $296,681,493
2026-05-15 annual 2026-12-31 $-2.01 $-2.04 ▼ 0.03 $105,178,652 $125,267,541
2026-05-15 annual 2029-12-31 $5.56 $5.42 ▼ 0.14 $362,143,486 $359,572,057
2026-05-15 annual 2027-12-31 $-2.34 $-2.34 $169,629,376 $173,589,376
2026-05-15 quarter 2026-06-30 $-0.38 $-0.35 ▲ 0.03 $20,407,334 $24,518,445
2026-05-15 quarter 2026-12-31 $-0.47 $-0.50 ▼ 0.03 $34,565,742 $42,999,076
2026-05-15 annual 2030-12-31 $7.31 $7.15 ▼ 0.16 $477,113,667 $473,447,000
2026-05-14 quarter 2026-09-30 $-0.49 $-0.35 ▲ 0.14 $25,794,544 $25,701,565
2026-05-14 quarter 2026-12-31 $-0.47 $-0.47 $35,486,013 $34,565,742
2026-05-14 quarter 2026-06-30 $-0.48 $-0.38 ▲ 0.10 $20,459,790 $20,407,334
2026-05-14 annual 2027-12-31 $-2.34 $-2.34 $169,821,527 $169,629,376
2026-05-14 annual 2028-12-31 $5.36 $5.38 ▲ 0.02 $299,192,671 $298,681,493
2026-05-14 annual 2026-12-31 $-2.31 $-2.01 ▲ 0.30 $106,320,445 $105,178,652
2026-05-13 annual 2030-12-31 $7.28 $7.31 ▲ 0.03 $477,113,667 $477,113,667
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms